Neogen Viroxide Super proven effective against African Swine Fever

ROCHDALE, United Kingdom, 18 March, 2019 — Neogen announced today that Neogen Viroxide Super has been proven effective against the African Swine Fever (ASF) virus at a dilution of 1:800.

Neogen, with continued investment in the efficacy testing of Neogen Viroxide Super, now offers a market-leading, broad spectrum disinfectant and emergency disease control solution worldwide.

[…]

Neogen Viroxide Super broad spectrum disinfectant launched

ROCHDALE, United Kingdom, 4 March, 2019 — Neogen announced today that it has added Neogen Viroxide Super disinfectant to the Neogen BioSecurity range.

Neogen Viroxide Super is a DEFRA-approved (FMD, SVD, General Orders), peroxygen-based disinfectant. It has an independently proven, non-resistant, oxidative chemistry to cause extensive damage to the protective mechanisms of microbial cells, giving […]

Scottish Government extends genomics partnership with Neogen

AYR, Scotland, 25 February, 2019 — Neogen Corporation (Nasdaq: NEOG) announced today the Scottish Government has formally extended its partnership with Neogen in Ayr, Scotland, to perform genomics testing as part of the government’s program to improve the country’s beef herd.

The genomic testing partnership was initiated in October 2016, and now has been […]

Neogen launches Attic Attack Rodent Bait Station

LEXINGTON, Ky., Feb. 7, 2019 — Baiting for rats and mice in attics just got easier.

Neogen’s new, innovative, patented Attic Attack Bait Station simply and effectively places rodent bait right where roof rats and mice are active — while eliminating the need to climb up into difficult-to-access attic spaces.

Attic Attack’s unique design allows […]

Adent completes transition as Neogen’s CEO

LANSING, Mich., Jan. 29, 2019 — Neogen Corporation (NASDAQ: NEOG) announced today that its transition of the responsibilities from James Herbert to John Adent as the company’s chief executive officer is now complete. Herbert will continue to serve as chairman of Neogen’s Board of Directors, and as the company’s director of strategic growth under […]

Neogen names Lilly VP of international business

LANSING, Mich., Jan. 9, 2019 — Neogen Corporation (NASDAQ: NEOG) announced today that it has promoted Dr. Jason Lilly to the newly created position of vice president of international business. Lilly joined Neogen in 2005, and has spent the past eight years as Neogen’s vice president of corporate development.

In his new role, Lilly will […]

Neogen reports second quarter results

LANSING, Mich., Dec. 20, 2018 — Neogen Corporation (NASDAQ: NEOG) announced today that its revenues for the second quarter of its 2019 fiscal year, which ended Nov. 30, increased 6% to $107,098,000, from the previous year’s second quarter revenues of $100,698,000. Current year-to-date revenues were $206,724,000, also up 6% compared to $194,907,000 for the same […]

USDA approves Reveal® Q+ for Aflatoxin with Raptor® reader

LANSING, Mich., Dec. 18, 2018 — Neogen Corporation announced today that the USDA’s Federal Grain Inspection Service (USDA-FGIS) has awarded a Certificate of Conformance for the Reveal® Q+ for Aflatoxin test kit used with Neogen’s new Raptor® Integrated Analysis Platform system.

Neogen’s Reveal Q+ for Aflatoxin test delivers fast and precise results, and is certified […]

Listeria Right Now™ AOAC-certified for additional surfaces

Neogen’s one-hour Listeria Right Now™ environmental pathogen detection system has been certified by the AOAC for use with samples on three additional surfaces.

Listeria Right Now achieved its original AOAC approval (license number #081802) in August for use with samples obtained from stainless steel and sealed concrete surfaces. The test kit has now also been […]

Neogen Board approves stock buyback

LANSING, Mich., Oct. 10, 2018 — Neogen Corporation (NEOG) announced today that its Board of Directors has authorized the repurchase of up to three million shares of the company’s common stock. The shares will be purchased in the open market or in negotiated transactions. There can be no assurance that any particular amount of shares […]